CytomX Therapeutics (CTMX) Non Operating Income (2014 - 2026)
CytomX Therapeutics (CTMX) reported Non Operating Income of -$7000.0 for Q1 2026, down 163.64% on a YoY basis from $11000.0 in Q1 2025, and down 40.0% quarter-over-quarter from -$5000.0 in Q4 2025.
CytomX Therapeutics (CTMX) Non Operating Income (2014 - 2026) Analysis & Trends
CytomX Therapeutics has reported Non Operating Income for 13 years, with the latest figure at -$7000.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 163.64% year-over-year to -$7000.0; the trailing twelve-month figure through Mar 2026 stood at $10000.0 (up 158.82% YoY), and the FY2025 full-year result was $28000.0, up 173.68% from the prior year.
- Non Operating Income for Q1 2026 stood at -$7000.0, down from -$5000.0 in the prior quarter.
- The five-year high for Non Operating Income was $296000.0 in Q2 2022, with the low at -$47000.0 in Q2 2023.
- Historically, Non Operating Income has averaged $17176.5 across 5 years, with a median of $1000.0 in 2022.
- Annual changes were most pronounced in 2024 — Non Operating Income sank 311.11% — and 2025, when it jumped 950.0%.
- CytomX Therapeutics' Non Operating Income stood at $1000.0 in 2022, then surged by 800.0% to $9000.0 in 2023, then slumped by 311.11% to -$19000.0 in 2024, then surged by 73.68% to -$5000.0 in 2025, then sank by 40.0% to -$7000.0 in 2026.
- The last three Non Operating Income figures came in at -$7000.0 (Q1 2026), -$5000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | -7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -11,000.00 |
| Dec 31, 2023 | 9,000.00 |
| Sep 30, 2023 | -7,000.00 |
| Jun 30, 2023 | -47,000.00 |
| Mar 31, 2023 | 15,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 296,000.00 |
| Mar 31, 2022 | 13,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | -13,000.00 |
| Jun 30, 2021 | -82,000.00 |